These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37769206)

  • 1. Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression.
    Boskovic P; Wilke N; Man KH; Lichter P; Francois L; Radlwimmer B
    Neuro Oncol; 2024 Feb; 26(2):251-265. PubMed ID: 37769206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA VPS18 Promotes Glioblastoma Progression by Regulating miR-1229-3p/BCAT1 Axis.
    Huang Q; Li W; Huang Y; Chen Q; Wei W
    Neurotox Res; 2022 Oct; 40(5):1138-1151. PubMed ID: 35776379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.
    Tönjes M; Barbus S; Park YJ; Wang W; Schlotter M; Lindroth AM; Pleier SV; Bai AHC; Karra D; Piro RM; Felsberg J; Addington A; Lemke D; Weibrecht I; Hovestadt V; Rolli CG; Campos B; Turcan S; Sturm D; Witt H; Chan TA; Herold-Mende C; Kemkemer R; König R; Schmidt K; Hull WE; Pfister SM; Jugold M; Hutson SM; Plass C; Okun JG; Reifenberger G; Lichter P; Radlwimmer B
    Nat Med; 2013 Jul; 19(7):901-908. PubMed ID: 23793099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
    Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
    Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.
    Zheng J; Liu Y; Wang J; Shi J; Li L; Jiang X; Tao L
    Aging (Albany NY); 2024 Feb; 16(3):2715-2735. PubMed ID: 38309289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.
    Thewes V; Simon R; Hlevnjak M; Schlotter M; Schroeter P; Schmidt K; Wu Y; Anzeneder T; Wang W; Windisch P; Kirchgäßner M; Melling N; Kneisel N; Büttner R; Deuschle U; Sinn HP; Schneeweiss A; Heck S; Kaulfuss S; Hess-Stumpp H; Okun JG; Sauter G; Lykkesfeldt AE; Zapatka M; Radlwimmer B; Lichter P; Tönjes M
    Oncogene; 2017 Jul; 36(29):4124-4134. PubMed ID: 28319069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
    Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
    Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired expression of BCAT1 relates to muscle atrophy of mouse model of sarcopenia.
    Ouyang H; Gao X; Zhang J
    BMC Musculoskelet Disord; 2022 May; 23(1):450. PubMed ID: 35562710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
    Hattori A; Tsunoda M; Konuma T; Kobayashi M; Nagy T; Glushka J; Tayyari F; McSkimming D; Kannan N; Tojo A; Edison AS; Ito T
    Nature; 2017 May; 545(7655):500-504. PubMed ID: 28514443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression.
    Qian L; Li N; Lu XC; Xu M; Liu Y; Li K; Zhang Y; Hu K; Qi YT; Yao J; Wu YL; Wen W; Huang S; Chen ZJ; Yin M; Lei QY
    Nat Metab; 2023 Jul; 5(7):1159-1173. PubMed ID: 37337119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCAT1 redox function maintains mitotic fidelity.
    Francois L; Boskovic P; Knerr J; He W; Sigismondo G; Schwan C; More TH; Schlotter M; Conway ME; Krijgsveld J; Hiller K; Grosse R; Lichter P; Radlwimmer B
    Cell Rep; 2022 Oct; 41(3):111524. PubMed ID: 36260995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
    Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
    Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma.
    Zhang B; Chen Y; Shi X; Zhou M; Bao L; Hatanpaa KJ; Patel T; DeBerardinis RJ; Wang Y; Luo W
    Cell Mol Life Sci; 2021 Jan; 78(1):195-206. PubMed ID: 32088728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma.
    Zhang B; Peng H; Zhou M; Bao L; Wang C; Cai F; Zhang H; Wang JE; Niu Y; Chen Y; Wang Y; Hatanpaa KJ; Copland JA; DeBerardinis RJ; Wang Y; Luo W
    Cancer Res; 2022 Jul; 82(13):2388-2402. PubMed ID: 35499760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.
    Cho HR; Hong B; Kim H; Park CK; Park SH; Park S; Choi SH
    Oncotarget; 2016 Oct; 7(43):69606-69615. PubMed ID: 27626306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation.
    Zhang T; Pan Z; Gao J; Wu Q; Bai G; Li Y; Tong L; Feng F; Lai M; Liu Y; Song P; Ning Y; Tang H; Luo W; Chen Y; Fang Y; Zhang H; Liu Q; Zhang Y; Wang H; Chen Z; Chen Y; Geng M; Ji H; Zhao G; Zhou H; Ding J; Xie H
    Signal Transduct Target Ther; 2024 Aug; 9(1):216. PubMed ID: 39143065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHIP-mediated ubiquitin degradation of BCAT1 regulates glioma cell proliferation and temozolomide sensitivity.
    Lu Z; Wang XY; He KY; Han XH; Wang X; Zhang Z; Qu XH; Chen ZP; Han XJ; Wang T
    Cell Death Dis; 2024 Jul; 15(7):538. PubMed ID: 39075053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched-chain amino acid transaminase 1 inhibition attenuates childhood asthma in mice by effecting airway remodeling and autophagy.
    Li J; Chen M; Lu L; Wang J; Tan L
    Respir Physiol Neurobiol; 2022 Dec; 306():103961. PubMed ID: 35961527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.